JO
BCAB icon

John Overdeck’s BioAtla BCAB Stock Holding History

John Overdeck’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,627
Closed -$46.2K – 4587
2025
Q4 		$46.2K Buy
1,627
+813
+100% +$31.9K ﹤0.01% 3945
2025
Q3 		$28K Sell
814
-838
-51% -$19.3K ﹤0.01% 3578
2025
Q2 		$32.7K Sell
1,652
-2,119
-56% -$43K ﹤0.01% 3094
2025
Q1 		$65.4K Buy
3,771
+1,067
+39% +$22.8K ﹤0.01% 3015
2024
Q4 		$79.9K Buy
2,704
+1,235
+84% +$104K ﹤0.01% 2994
2024
Q3 		$129K Sell
1,469
-24
-2% -$2.01K ﹤0.01% 2866
2024
Q2 		$102K Sell
1,493
-2,569
-63% -$306K ﹤0.01% 2817
2024
Q1 		$699K Buy
4,062
+645
+19% +$80.1K ﹤0.01% 2172
2023
Q4 		$420K Buy
3,417
+1,551
+83% +$134K ﹤0.01% 2548
2023
Q3 		$159K Sell
1,866
-2,104
-53% -$268K ﹤0.01% 2682
2023
Q2 		$595K Sell
3,970
-1,922
-33% -$331K ﹤0.01% 2251
2023
Q1 		$789K Buy
5,892
+112
+2% +$20.2K ﹤0.01% 1995
2022
Q4 		$2.38M Buy
5,780
+618
+12% +$256K 0.01% 1224
2022
Q3 		$1.99M Sell
5,162
-4,543
-47% -$1.49M 0.01% 1152
2022
Q2 		$1.38M Sell
9,705
-1,644
-14% -$262K ﹤0.01% 1388
2022
Q1 		$2.84M Buy
11,349
+7,731
+214% +$3.23M 0.01% 1184
2021
Q4 		$3.55M Buy
+3,618
New +$4.63M 0.01% 1432

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

John Overdeck's BCAB Position: Q1 2026 in Review

John Overdeck sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 1,627 shares — an estimated $46.2K sold.

John Overdeck first reported a position in BCAB in Q4 2021 and held it in 17 quarters. The position peaked at $3.55M in Q4 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • John Overdeck reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 1,627 BioAtla shares in Q1 2026, an estimated $46.2K.
  • John Overdeck first reported a position in BioAtla in Q4 2021 and held it in 17 quarters.
  • John Overdeck's BioAtla position peaked at $3.55M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.